tiprankstipranks
Trending News
More News >

Cytokinetics price target lowered to $84 from $103 at Mizuho

Mizuho analyst Salim Syed lowered the firm’s price target on Cytokinetics (CYTK) to $84 from $103 and keeps an Outperform rating on the shares. The firm updated the company’s model post the Q1 report.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1